Pragmatic criteria to define chronic pseudomonas aeruginosa infection among adults with cystic fibrosis-Reference-Cited by-同舟云学术

Pragmatic criteria to define chronic pseudomonas aeruginosa infection among adults with cystic fibrosis

Published:2018-08-18 Issue:11 Volume:37 Page:2219-2222
ISSN:0934-9723
Container-title:European Journal of Clinical Microbiology & Infectious Diseases
language:en
Short-container-title:Eur J Clin Microbiol Infect Dis

Author:

Hoo Zhe Hui^ORCID,Coates Elizabeth,Maguire Chin,Cantrill Hannah,Shafi Nadia,Nash Edward F.,McGowan Angela,Bourke Stephen J.,Flight William G.,Daniels Thomas V.,Nightingale Julia A.,Allenby Mark I.,Curley Rachael,Wildman Martin J.

Funder

Research Trainees Coordinating Centre

Programme Grants for Applied Research

Publisher

Springer Science and Business Media LLC

Subject

Infectious Diseases,Microbiology (medical),General Medicine

Link

http://link.springer.com/article/10.1007/s10096-018-3358-8/fulltext.html

Reference22 articles.

1. Salsgiver EL, Fink AK, Knapp EA, LiPuma JJ, Olivier KN, Marshall BC, Saiman L (2016) Changing epidemiology of the respiratory bacteriology of patients with cystic fibrosis. Chest 149:390–400. https://doi.org/10.1378/chest.15-0676

2. Lee TW, Brownlee KG, Conway SP, Denton M, Littlewood JM (2003) Evaluation of a new definition for chronic Pseudomonas aeruginosa infection in cystic fibrosis patients. J Cyst Fibros 2:29–34. https://doi.org/10.1016/S1569-1993(02)00141-8

3. Mogayzel PJ Jr, Naureckas ET, Robinson KA, Brady C, Guill M, Lahiri T, Lubsch L, Matsui J, Oermann CM, Ratjen F, Rosenfeld M, Simon RH, Hazle L, Sabadosa K, Marshall BC, Cystic Fibrosis Foundation Pulmonary Clinical Practice Guidelines Committee (2014) Cystic Fibrosis Foundation pulmonary guideline. Pharmacologic approaches to prevention and eradication of initial Pseudomonas aeruginosa infection. Ann Am Thorac Soc 11:1640–1650. https://doi.org/10.1513/AnnalsATS.201404-166OC

4. Mogayzel PJ Jr, Naureckas ET, Robinson KA, Mueller G, Hadjiliadis D, Hoag JB, Lubsch L, Hazle L, Sabadosa K, Marshall B, Pulmonary Clinical Practice Guidelines Committee (2013) Cystic fibrosis pulmonary guidelines. Chronic medications for maintenance of lung health. Am J Respir Crit Care Med 187:680–689. https://doi.org/10.1164/rccm.201207-1160OE

5. da Silva Filho LV, Tateno AF, Martins KM, Azzuz Chernishev AC, Garcia Dde O, Haug M, Meisner C, Rodrigues JC, Döring G (2007) The combination of PCR and serology increases the diagnosis of Pseudomonas aeruginosa colonization/infection in cystic fibrosis. Pediatr Pulmonol 42:938–944. https://doi.org/10.1002/ppul.20686

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A comparison of the CFHH criteria against the Leeds criteria in determining the Pseudomonas aeruginosa status among adults with cystic fibrosis;Respiratory Medicine;2020-09

2. Prevention of chronic infection with Pseudomonas aeruginosa infection in cystic fibrosis;Current Opinion in Pulmonary Medicine;2019-11

3. The renoprotective effect of concomitant fosfomycin in the treatment of pulmonary exacerbations in cystic fibrosis;Clinical Kidney Journal;2019-02-07